- Texas man arrested for powder-letter hoax
- Islamic State opens ‘marriage bureau’ for single jihadists
- Drone almost blocks California firefighting planes
- Tornado rips off roofs, downs trees near Boston
- GOP: Environmental rules keeping agents from accessing border
- John Kerry: Millions displaced by religious fighting in 2013
- Federal appeals court rules against Virginia’s gay marriage ban
- White House says Russia ‘losing’ war in Ukraine
- Hamas turns to North Korea for weapons deal, Iran for money
- Syrian casualties surge as jihadis consolidate
Question of the Day
New changes aimed at improving transparency
BERLIN | Facebook Inc. has agreed to make several changes to its services to improve transparency and better protect the personal data of its millions of users outside of the U.S., following an in-depth audit of its international headquarters that was released Wednesday.
The social media company, based in Palo Alto, Calif., agreed to changes including asking European users if they wanted to partake in its Facial Recognition, reworking its policies of retaining and deleting private data, and reducing the amount of information collected about people who are not logged into Facebook, the company said in response to the report of the Irish Data Protection Commissioner.
Facebook’s international headquarters are based in Dublin. Ireland is a member of the European Union, meaning the company is required to comply with European data privacy laws, which are more stringent than those that apply in the United States, particularly regarding how long data can be retained.
The company has agreed to present its results in a follow-up to the report in July.
Judge upholds $327M verdict over J&J marketing
TRENTON | A South Carolina judge has upheld a $327 million civil penalty against Johnson & Johnson, which was found guilty by a jury of overstating the safety and effectiveness of antipsychotic drug Risperdal.
Attorneys for the state say it’s the biggest verdict in the country over the marketing of Risperdal.
The pill for schizophrenia and bipolar disorder once brought J&J more than $3.4 billion in annual sales.
But it’s been mired for years in litigation over alleged kickbacks, promotion for unapproved uses and other efforts to boost Risperdal over competing drugs. Dozens of pending state and federal cases allege illegal marketing practices for Risperdal, including one in which Texas is seeking up to $1 billion.
J&J of New Brunswick, N.J., says it will appeal the South Carolina ruling.
Apple buys startup for about $400M
© Copyright 2014 The Washington Times, LLC. Click here for reprint permission.
TWT Video Picks
By David Keene
Allowing states to innovate could reduce dependency on bureaucracy
- D.C. seeks to stay judge's order allowing gun owners to carry in public
- Hillary Clinton: Forget Obama, George W. Bush made her 'proud to be an American'
- Illegal immigrants demand representation in White House meetings
- Iraqi Christians rally at White House: 'Obama, Obama, where are you?'
- Tennessee Gov. Haslam slams White House for secret dump of illegals in his state
- White House defends Kerry failure to broker Middle East cease-fire
- NAPOLITANO: What if our democracy is a fraud?
- Romney would win popular vote in rematch against Obama: CNN poll - Washington Times#.U9ZSgi7-CXU.twi
- Russia violating 1987 nuclear missile treaty
- RAHN: When money mischief goes global
Obama's biggest White House 'fails'
Celebrities turned politicians
Athletes turned actors
20 gadgets that changed the world
Fighting in Iraq